📣 Have you seen this recent publication in Bone Marrow Transplantation?
📃 Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC) ⬇️
nature.com/articles/s4140…
#MedTwitter #haematology #HCT #BMTsm #celltherapy #transplantation
This week has been bad.
1. A #AYAsm #leukemia besties passed away. Not all of us get successfully treatments. #AMLsm #BMTsm
2. Having #GVHD sucks
3. Getting a PhD is hard
4. Do I even belong to #celltherapy or #bioengineering
5. Yay, science
#keepmovingforward #IntotheNextEra
¿Sabías que estamos más cerca que nunca de desbloquear el potencial completo de los trasplantes en la medicina?
#TrasplantesMédicos #InnovaciónHematológica #BMTsm
Okay Rahul Banerjee, MD, FACP --here is the punk rock version of the full song 'CAR-T Revolution'
#mmsm #lymsm #bmtsm #CellTherapy #immunotherapy #CARTcells #cellulartherapy
Aaron Goodman - “Papa Heme”
@MyelomaTeacher - Cindy Chmielewski
Jack Aiello
Manni Mohyuddin
Oncology Brothers
Al-Ola A Abdallah MD (USMIRC)
Luciano J Costa
Mike Thompson, MD, PhD, FASCO…
MRD negative status (10e-5 to -6) 1 year after AutoHCT and Len maintenance is associated with longer PFS and OS in MM. STaMINA trial #bmtsm #mmsm Marcelo Pasquini BMT CTN Theresa Hahn, PhD Phari Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic HSCT with PTCY
nature.com/articles/s4140…
Bone Marrow Transplantation The EBMT Trainee Committee #BMTsm #MDSsm #leusm
Our DLBCL chapter with Francisco Vega ➡️shorturl.at/fmnGY🩸🔬
#hemepath #lymsm #molpath #pathtwitter #medtwitter #pathX #MedX #SoMe #MedEd #bmtSM
#EBMT24
Carmem Bonfim on #BMTsm in #fanconianemia
- Pre BM aspirate for blast% in FA to decide intensity of conditioning regimen
- Flu essential in FA when using MUD
- AML/MDS preBMT portends inferior survival
- While Haplo TCR dep BMT doesn’t need GVHD ppx, they need 2 Gy TBI.
Live from New York, it’s Saturday Night! #Tandem24 #bmtsm #CellularTherapy . #noActuallyWereInSanAntonio #puppy !
Lots of groundbreaking work we can’t wait to discuss! Stay tuned for interviews and Tandem roundup! Joshua Fein Mohammad Alhomoud
Postinduction qRT-PCR MRD+ NPM1 AML patients benefit from allogeneic in CR1
- 3 yr OS with CR1-allo vs without: 61% vs 24%; HR 0.39, P < .001)
- But no benefit for MRD− patients (irrespective of FLT3-ITD)
doi.org/10.1182/blood.…
#leusm #BMTsm Mike Dennis The EBMT Trainee Committee
Editorial on thrombotic microangiopathy in #BMTsm by Krishna Gundabolu MBBS; MS UNMC Heme Onc Blood Journal ashpublications.org/blood/article/…